Learning Objectives

At the conclusion of this session, the participant should be able to:

1) describe the medical treatment options for subdural hematoma
2) describe new interventional/surgical options for chronic subdural hematoma
3) describe the pathophysiology of chronic subdural hematoma formation.

Speaker:

Matthew Kole MD, Staff, Geisinger - nothing to disclose.

Moderator:

Edward Monaco, MD, Staff, Geisinger - nothing to disclose.

Session date: 
11/17/2023 - 7:00am to 8:00am EST
Location: 
Virtual Activity Using Microsoft Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.